23 January 2025

DEAL NEWS: WIPIT advises Sonormed shareholders on exit to InfectoPharm

InfectoPharm Arzneimittel und Consilium GmbH, a family-owned company specializing in the development and advancement of pharmaceuticals, has acquired all shares of Sonormed GmbH. Known as the developer of the first prescription-based app, Sonormed is a pioneer in the field of digital health applications (DiGAs).

Our Berlin partner Prof. Dr. Hans-Eric Rasmussen-Bonne, LL.M. advised on the transaction on behalf of the founders, VC investors, and business angels.

Further information can be found in the press release from the High-Tech Gründerfonds.

RECENT NEWS
1 July 2026

WIPIT advises CollimateHealth on successful €6m seed funding round

read NOW
1 July 2026

WIPIT expands its digital, media, and technology law practice: Dr. Philipp-Christian Thomale joins the partnership effective June 1, 2026

read NOW